Chimeric Therapeutics



Chimeric Therapeutics aspires to be a leader in cell therapy and to develop life-changing medicines for humankind

  • We put patients first
  • We demonstrate compassion and kindness to our patients and their families
  • We strive to do the right thing
  • Our people are our greatest assets
  • We are intellectually curious
  • Our science is data driven
  • We are collaborative
  • We value relationships based on trust and integrity
  • We will be good stewards of our investors’ capital
  • We will admit our mistakes and seek to learn from them
  • We aim to have fun
  • The value of our output must be worth more than the inputs

Latest Media Releases

Chimeric Therapeutics - Appendix 4C - quarterly

23/04/2021 12:24:00

Chimeric Therapeutics Limited (“the Company”) (ASX: CHM), a clinical stage cell therapy company, is pleased to provide a summary of its activities for the quarter ended 31 March 2021. …

Latest News